Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-dependent neutral amino acid transporter B0AT1 (SLC6A19) is a membrane protein responsible for the sodium-coupled uptake of neutral amino acids across the apical membrane of epithelial cells in the intestine and proximal tubules of the kidney[2][3][4][8][9]. This transporter is crucial for absorption of dietary amino acids in the gut and their reabsorption in the kidney, thereby preventing excessive amino acid loss in urine. Genetic defects in SLC6A19 result in Hartnup disease, characterized by aminoaciduria and variable neuropsychiatric or dermatological symptoms. B0AT1 belongs to the solute carrier 6 family of transporters, is sodium-dependent but chloride-independent, and plays a fundamental role in systemic amino acid homeostasis[1][2][3][4][8][9].
Inhibitors or mutations disrupt neutral amino acid uptake across intestinal and renal epithelium
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent neutral amino acid transporter B0AT1 (B0AT1).